Home > Newsletters > Drug Industry Daily > Mold Troubles at Sanofi Pasteur’s Toronto Plant Prompt Shutdown, Shortages
Drug Industry Daily
July 16, 2012 | Vol. 11 No. 138
Mold Troubles at Sanofi Pasteur’s Toronto Plant Prompt Shutdown, Shortages
Sanofi Pasteur has suspended production at its Toronto, Canada, plant to address mold troubles that recently landed the drugmaker an FDA Form 483 and prompted global shortages of a tuberculosis (TB) vaccine and a bladder cancer treatment produced there, the company says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.